Business · 10/05/2017Updated: 10/17/2026 · 1 min read
FDA Announces Draft Revisions to Blueprint for Prescriber Education on Extended-Release and Long-Acting Opioids
Summary
The Food and Drug Administration (FDA) is releasing draft revisions to its Blueprint for Prescriber Education for Extended-Release and Long-Acting Opioid Analgesics, seeking public comment ahead of a workshop on May 9-10, 2017
Original source language: Federal Register — Food and Drug AdministrationOpen original release →